Cited by 2,149Multiple Sclerosis Research StudiesT-cell and B-cell ImmunologyPsoriasis: Treatment and Pathogenesis

The DOI matches its Crossref record; 362 of the 362 references it cites were found in a registry or an index.

IMMUNOLOGY OF MULTIPLE SCLEROSIS

Sospedra, Mireia, Martin, Roland·2005·Annual Review of Immunology

DOI 10.1146/annurev.immunol.23.021704.115707

Open this paper in CoChat — free account

Abstract

Multiple sclerosis (MS) develops in young adults with a complex predisposing genetic trait and probably requires an inciting environmental insult such as a viral infection to trigger the disease. The activation of CD4+ autoreactive T cells and their differentiation into a Th1 phenotype are a crucial events in the initial steps, and these cells are probably also important players in the long-term evolution of the disease. Damage of the target tissue, the central nervous system, is, however, most likely mediated by other components of the immune system, such as antibodies, complement, CD8+ T cells, and factors produced by innate immune cells. Perturbations in immunomodulatory networks that include Th2 cells, regulatory CD4+ T cells, NK cells, and others may in part be responsible for the relapsing-remitting or chronic progressive nature of the disease. However, an important paradigmatic shift in the study of MS has occurred in the past decade. It is now clear that MS is not just a disease of the immune system, but that factors contributed by the central nervous system are equally important and must be considered in the future.

Integrity signals

Registry

Crossref · 10.1146/annurev.immunol.23.021704.115707

Cites

362 of 362 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. M. (2003) · Science · doi:10.1126/science.1078231 · Cited by 2,000
Use of a cDNA microarray to analyse gene expression patterns in human cancer
DeRisi, J. L., Penland, L., Brown, P. O., Bittner, M. L., Meltzer, P. S., Ray, M., Chen, Y.-W., Su, Y. A., & Trent, J. M. (1996) · Nature Genetics · doi:10.1038/ng1296-457 · Cited by 1,952
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali‐Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J. E., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,918
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher‐Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,858
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M. N., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,683
Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis
Johnson, K., Brooks, B., Cohen, J. A., Ford, C., Goldstein, J., Lisak, R., Myers, L., Panitch, H., Rose, J., Schiffer, R., et al. (1995) · Neurology · doi:10.1212/wnl.45.7.1268 · Cited by 1,667

Show all 362 references

Research works printed but not linked: 12

McFarland HF, 1999, Am. J. Neuroradiol., 20, 1777
10.1172/JCI200421357 · DOI
Charcot J, 1868, Gaz. Hopitaux, 41, 554
Remlinger J, 1905, Ann. Inst. Pasteur, 19, 625
Berger T, 1997, Lab. Invest., 76, 355
10.1097/00019052-200306000-00004 · DOI
Sharief MK, 1991, Brain, 114, 181
Bornstein MB, 1959, Trans. Am. Neurol. Assoc., 84, 165
10.1002/1531-8249(200006)47:6<694::AID-ANA2>3.0.CO;2-W · DOI
Linington C, 1988, Am. J. Pathol., 130, 443
Benczur M, 1980, Clin. Exp. Immunol., 39, 657
10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-# · DOI

Sorted by citations

Items 101–200 of 1,006

IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease
Zepp, J. A., Wu, L., & Li, X. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.02.007 · Cited by 227
Enhanced number and activity of mitochondria in multiple sclerosis lesions
Witte, M. E., Bø, L., Rodenburg, R. J., Beliën, J. A. M., Musters, R. J. P., Hazes, T., Wintjes, L. T., Smeitink, J. A. M., Geurts, J. J. G., de Vries, H. E., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2582 · Cited by 223
Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis
Kimura, K., Hohjoh, H., Fukuoka, M., Sato, W., Oki, S., Tomi, C., Yamaguchi, H., Kondo, T., Takahashi, R., & Yamamura, T. (2017) · Nature Communications · doi:10.1038/s41467-017-02406-2 · Cited by 223
Passive induction of experimental allergic encephalomyelitis
Stromnes, I. M., & Goverman, J. M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.284 · Cited by 238
Current Views on the Roles of Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis
Behi, M. E., Rostami, A. M., & Ćirić, B. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9188-9 · Cited by 222
Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis
Carbajal, K. S., Schaumburg, C. S., Strieter, R. M., Kane, J. A. C., & Lane, T. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006375107 · Cited by 226
Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells
Kang, Z., Wang, C., Zepp, J., Wu, L., Sun, K., Zhao, J., Chandrasekharan, U., DiCorleto, P. E., Trapp, B. D., Ransohoff, R. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3505 · Cited by 218
Th17 Cells and Autoimmune Encephalomyelitis (EAE/MS)
Aranami, T., & Yamamura, T. (2008) · Allergology International · doi:10.2332/allergolint.r-07-159 · Cited by 218
Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection
Zeis, T., Graumann, U., Reynolds, R., & Schaeren‐Wiemers, N. (2007) · Brain · doi:10.1093/brain/awm291 · Cited by 214
Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response
Kwon, H.-K., Kim, G.-C., Kim, Y., Hwang, W., Jash, A., Sahoo, A., Kim, J.-E., Nam, J. H., & Im, S.-H. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.01.001 · Cited by 212
T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis
Hedegaard, C. J., Krakauer, M., Bendtzen, K., Lund, H., Sellebjerg, F. T., & Nielsen, C. H. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02837.x · Cited by 215
The Master Switch: The Role of Mast Cells in Autoimmunity and Tolerance
Sayed, B. A., Christy, A. L., Quirion, M. R., & Brown, M. A. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090320 · Cited by 214
Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25 + Foxp3 + regulatory T cells
Benkhoucha, M., Santiago‐Raber, M., Schneiter, G., Chofflon, M., Funakoshi, H., Nakamura, T., & Lalive, P. H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912437107 · Cited by 210
A basic overview of multiple sclerosis immunopathology
Grigoriadis, N., & Pesch, V. V. (2015) · European Journal of Neurology · doi:10.1111/ene.12798 · Cited by 220
Functional epistasis on a common MHC haplotype associated with multiple sclerosis
Gregersen, J. W., Kranc, K. R., Ke, X., Svendsen, P., Madsen, L. S., Thomsen, A. R., Cardon, L. R., Bell, J. I., & Fugger, L. H. (2006) · Nature · doi:10.1038/nature05133 · Cited by 207
Environmental risk factors for multiple sclerosis
Salzer, J. (2013) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 202
Sex: A Significant Risk Factor for Neurodevelopmental and Neurodegenerative Disorders
Pinares-Garcia, P., Stratikopoulos, M., Zagato, A., Loke, H., & Lee, J. (2018) · Brain Sciences · doi:10.3390/brainsci8080154 · Cited by 200
Oxidative Stress-Induced Signaling Pathways Implicated in the Pathogenesis of Parkinson’s Disease
Gaki, G. S., & Papavassiliou, A. G. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8294-x · Cited by 206
Cladribine
Leist, T. P., & Weissert, R. (2011) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e318204cd90 · Cited by 200
Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases
Pauli, F. D., Mader, S., Rostasy, K. M., Schanda, K., Bajer-Kornek, B., Ehling, R., Deisenhammer, F., Reindl, M., & Berger, T. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.11.013 · Cited by 200
Simvastatin Inhibits IL-17 Secretion by Targeting Multiple IL-17-Regulatory Cytokines and by Inhibiting the Expression of IL-17 Transcription Factor RORC in CD4+ Lymphocytes
Zhang, X., Jin, J., Peng, X., Ramgolam, V. S., & Markovic‐Plese, S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6988 · Cited by 203
CD4+CD28null T Cells in Autoimmune Disease: Pathogenic Features and Decreased Susceptibility to Immunoregulation
Thewissen, M. M., Somers, V. A., Hellings, N., Fraussen, J., Damoiseaux, J. G. M. C., & Stinissen, P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.6514 · Cited by 199
The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells
Ifergan, I., Kébir, H., Bernard, M., Wosik, K., Dodelet-Devillers, A., Cayrol, R., Arbour, N., & Prat, A. (2007) · Brain · doi:10.1093/brain/awm295 · Cited by 199
The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets
Hohlfeld, R., Dornmair, K., Meinl, E., & Wekerle, H. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00334-8 · Cited by 205
The epigenetics of autoimmunity
Meda, F., Folci, M., Baccarelli, A., & Selmi, C. F. (2011) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.78 · Cited by 198
Estrogen and testosterone therapies in multiple sclerosis
Gold, S. M., & Voskuhl, R. R. (2009) · Progress in brain research · doi:10.1016/s0079-6123(09)17516-7 · Cited by 200
Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity
Zajonc, D. M., Maricic, I., Wu, D., Halder, R. C., Roy, K. C., Wong, C., Kumar, V., & Wilson, I. A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051625 · Cited by 192
Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease
Basu, S., & Dittel, B. N. (2011) · Immunologic Research · doi:10.1007/s12026-011-8210-5 · Cited by 197
Akt1 is critical for acute inflammation and histamine-mediated vascular leakage
Lorenzo, A. D., Fernandez-Hernando, C. F., Cirino, G., & Sessa, W. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904073106 · Cited by 191
Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis
Miyazaki, Y., Miyake, S., Chiba, A., Lantz, O. J., & Yamamura, T. (2011) · International Immunology · doi:10.1093/intimm/dxr047 · Cited by 201
microRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination
Mycko, M. P., Cichalewska, M., Machlańska, A., Ćwiklińska, H., Mariasiewicz, M., & Selmaj, K. W. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114325109 · Cited by 190
T Cell-Mediated Autoimmune Disease Due to Low-Affinity Crossreactivity to Common Microbial Peptides
Harkiolaki, M., Holmes, S. L., Svendsen, P., Gregersen, J. W., Jensen, L. T., McMahon, R. M., Friese, M. A., van Boxel, G., Etzensperger, R., Tzartos, J. S., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.01.009 · Cited by 198
Virgin Olive Oil and Health: Summary of the III International Conference on Virgin Olive Oil and Health Consensus Report, JAEN (Spain) 2018
Gaforio, J. J., Visioli, F., Alarcón-de-la-Lastra, C., Castañer, O., Delgado-Rodríguez, M., Fitó, M., Hernández, A. F., Huertas, J. R., Martínez-González, M. A., Menendez, J. A., et al. (2019) · Nutrients · doi:10.3390/nu11092039 · Cited by 187
Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions
Koning, N., Bö, L., Hoek, R. M., & Huitinga, I. (2007) · Annals of Neurology · doi:10.1002/ana.21220 · Cited by 186
Increased Osteopontin Expression in Dendritic Cells Amplifies IL-17 Production by CD4+ T Cells in Experimental Autoimmune Encephalomyelitis and in Multiple Sclerosis
Murugaiyan, G., Mittal, A., & Weiner, H. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7480 · Cited by 186
Structure of a human autoimmune TCR bound to a myelin basic protein self‐peptide and a multiple sclerosis‐associated MHC class II molecule
Li, Y., Huang, Y., Lue, J., Quandt, J. A., Martinꝉ, R., & Mariuzza, R. A. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600771 · Cited by 185
Self-citation
NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases.
Sun, X.-F., & Zhang, H. (2007) · PubMed · doi:10.14670/hh-22.1387 · Cited by 185
Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis
Friese, M. A., Jakobsen, K. B., Friis, L. S., Etzensperger, R., Craner, M. J., McMahon, R. M., Jensen, L. T., Huygelen, V., Jones, E. Y., Bell, J. I., et al. (2008) · Nature Medicine · doi:10.1038/nm.1881 · Cited by 184
MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium.
Dousset, V., Brochet, B., Deloire, M. S. A., Lagoarde, L., Barroso, B., Caillé, J. M., & Petry, K. G. (2006) · PubMed Central · Cited by 182
Fas–Fas Ligand: Checkpoint of T Cell Functions in Multiple Sclerosis
Volpe, E., Sambucci, M., Battistini, L., & Borsellino, G. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00382 · Cited by 197
The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain
Rus, H., Pardo, C. A., Hu, L., Darrah, E., Cudrici, C. D., Niculescu, T., Niculescu, F. I., Mullen, K. M., Allie, R., Guo, L., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501770102 · Cited by 181
Peripheral T Cells Are the Therapeutic Targets of Glucocorticoids in Experimental Autoimmune Encephalomyelitis
Wüst, S., van den Brandt, J., Tischner, D., Kleiman, A., Tuckermann, J. P., Gold, R., Lühder, F., & Reichardt, H. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.8434 · Cited by 181
Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis
Garren, H., Robinson, W. H., Krasulová, E., Havrdová, E., Nadj, Č., Selmaj, K. W., Losy, J., Nadj, I., Radue, E. W., Kidd, B. A., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21370 · Cited by 180
Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen
Ponomarenko, N. A., Durova, O. M., Vorobiev, I. I., Belogurov, A. A., Kurkova, I. N., Petrenko, A. G., Telegin, G. B., Suchkov, S. V., Киселев, С. Л., Lagarkova, M. A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509849103 · Cited by 179
Current and Future Biomarkers in Multiple Sclerosis
Yang, J., Hamade, M., Wu, Q., Wang, Q., Axtell, R. C., Giri, S., & Mao‐Draayer, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115877 · Cited by 190
Glial toll-like receptor signaling in central nervous system infection and autoimmunity
Carpentier, P. A., Duncan, D. S., & Miller, S. D. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.08.011 · Cited by 182
Innate Immunity in Multiple Sclerosis: Myeloid Dendritic Cells in Secondary Progressive Multiple Sclerosis Are Activated and Drive a Proinflammatory Immune Response
Karni, A., Abraham, M., Monsonego, A., Cai, G., Freeman, G. J., Hafler, D. A., Khoury, S. J., & Weiner, H. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.4196 · Cited by 177
The complement cascade: Yin-Yang in neuroinflammation—neuro-protection and -degeneration
Alexander, J. J., Anderson, A. J., Barnum, S. R., Stevens, B., & Tenner, A. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05668.x · Cited by 177
MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis
Zhang, J., Cheng, Y., Cui, W., Li, M., Li, B., & Guo, L. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.09.019 · Cited by 178
The Immunopathophysiology of Multiple Sclerosis
Wu, G. F., & Álvarez, E. (2011) · Neurologic Clinics · doi:10.1016/j.ncl.2010.12.009 · Cited by 186
Modeling the heterogeneity of multiple sclerosis in animals
Simmons, S. B., Pierson, E. R., Lee, S. Y., & Goverman, J. M. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.04.006 · Cited by 184
Resveratrol (trans-3,5,4′-Trihydroxystilbene) Ameliorates Experimental Allergic Encephalomyelitis, Primarily via Induction of Apoptosis in T Cells Involving Activation of Aryl Hydrocarbon Receptor and Estrogen Receptor
Singh, N. P., Hegde, V. L., Hofseth, L. J., Nagarkatti, M., & Nagarkatti, P. S. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038984 · Cited by 174
Human Induced Pluripotent Stem Cell-Derived Astrocytes Are Differentially Activated by Multiple Sclerosis-Associated Cytokines
Perriot, S., Mathias, A., Perriard, G., Canales, M., Jonkmans, N., Merienne, N., Meunier, C., El Kassar, L., Perrier, A. L., Laplaud, D.-A., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.09.015 · Cited by 171
Pathogenic CD8+ T cells in multiple sclerosis
Friese, M. A., & Fugger, L. H. (2009) · Annals of Neurology · doi:10.1002/ana.21744 · Cited by 170
Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis
Vogt, J., Paul, F., Aktas, O., Müller‐Wielsch, K., Dörr, J., Dörr, S., Bharathi, B. S., Glumm, R., Schmitz, C., Steinbusch, H., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21719 · Cited by 157
A role for CXCL12 (SDF-1α) in the pathogenesis of multiple sclerosis: Regulation of CXCL12 expression in astrocytes by soluble myelin basic protein
Calderon, T. M., Eugenín, E. A., Lopez, L., Kumar, S. S., Hesselgesser, J., Raine, C. S., & Berman, J. W. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.05.003 · Cited by 166
Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia
Li, Y., Chu, N., Hu, A., Gran, B., Rostami, A. M., & ZHANG, G. (2006) · Brain · doi:10.1093/brain/awl273 · Cited by 170
Leukemia Inhibitory Factor Inhibits T Helper 17 Cell Differentiation and Confers Treatment Effects of Neural Progenitor Cell Therapy in Autoimmune Disease
Cao, W., Yang, Y., Wang, Z., Liu, A., Fang, L., Wu, F., Hong, J., Shi, Y., Leung, S., Dong, C., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.06.011 · Cited by 168
Induction of Antigen-Specific Tolerance in Multiple Sclerosis After Immunization With DNA Encoding Myelin Basic Protein in a Randomized, Placebo-Controlled Phase 1/2 Trial
Bar‐Or, A., Vollmer, T. R., Antel, J. P., Arnold, D. L., Bodner, C., Campagnolo, D. I., Gianettoni, J., Jalili, F., Kachuck, N. J., Lapierre, Y., et al. (2007) · Archives of Neurology · doi:10.1001/archneur.64.10.nct70002 · Cited by 166
CD40 Expression by Microglial Cells Is Required for Their Completion of a Two-Step Activation Process during Central Nervous System Autoimmune Inflammation
Ponomarev, E. D., Shriver, L. P., & Dittel, B. N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1402 · Cited by 165
Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE
Christy, A. L., Walker, M. E., Hessner, M. J., & Brown, M. A. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.11.003 · Cited by 172
Type I interferon pathway in CNS homeostasis and neurological disorders
Blank, T., & Prinz, M. (2017) · Glia · doi:10.1002/glia.23154 · Cited by 172
Activation of p38 MAPK in CD4 T cells controls IL-17 production and autoimmune encephalomyelitis
Noubade, R., Krementsov, D. N., del Río, R., Thornton, T. M., Nagaleekar, V. K., Saligrama, N., Spitzack, A., Spach, K. M., Sabio, G., Davis, R. J., et al. (2011) · Blood · doi:10.1182/blood-2011-02-336552 · Cited by 167
Meningeal Mast Cells Affect Early T Cell Central Nervous System Infiltration and Blood-Brain Barrier Integrity through TNF: A Role for Neutrophil Recruitment?
Sayed, B. A., Christy, A. L., Walker, M. E., & Brown, M. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000126 · Cited by 163
Central nervous system-directed effects of FTY720 (fingolimod)
Miron, V. E., Schubart, A., & Antel, J. P. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.06.031 · Cited by 166
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
Basler, M., Mundt, S., Muchamuel, T., Moll, C., Jiang, J., Groettrup, M., & Kirk, C. J. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201303543 · Cited by 163
Role of gender in multiple sclerosis: Clinical effects and potential molecular mechanisms
Greer, J. M., & McCombe, P. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.03.003 · Cited by 165
Glucocorticoids and endothelial cell barrier function
Salvador, E., Shityakov, S., & Förster, C. Y. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1762-z · Cited by 164
Potential targeting of B7‐H4 for the treatment of cancer
Podojil, J. R., & Miller, S. D. (2017) · Immunological Reviews · doi:10.1111/imr.12530 · Cited by 160
The value of animal models for drug development in multiple sclerosis
Friese, M. A. (2006) · Brain · doi:10.1093/brain/awl083 · Cited by 159
Sodium chloride promotes pro-inflammatory macrophage polarization thereby aggravating CNS autoimmunity
Hucke, S., Eschborn, M., Liebmann, M., Herold, M. V. B., Freise, N., Engbers, A., Ehling, P., Meuth, S. G., Roth, J., Kuhlmann, T., et al. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.11.001 · Cited by 161
The Essential Role of Epstein-Barr Virus in the Pathogenesis of Multiple Sclerosis
Pender, M. P. (2010) · The Neuroscientist · doi:10.1177/1073858410381531 · Cited by 157
From classic to spontaneous and humanized models of multiple sclerosis: Impact on understanding pathogenesis and drug development
Ben‐Nun, A., Kaushansky, N., Kawakami, N., Krishnamoorthy, G., Berer, K., Liblau, R., Hohlfeld, R., & Wekerle, H. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.06.004 · Cited by 165
Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis
Farez, M., Correale, J. D., Armstrong, M. J., Rae-Grant, A. D., Gloss, D. S., Donley, D. K., Holler‐Managan, Y., Kachuck, N. J., Jeffery, D., Beilman, M., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008157 · Cited by 156
Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis
Noorbakhsh, F., Tsutsui, S., Vergnolle, N., Boven, L. A., Shariat, N., Vodjgani, M., Warren, K. G., Andrade‐Gordon, P., Hollenberg, M. D., & Power, C. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052148 · Cited by 153
Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target
Liu, R., Du, S., Zhao, L., Jain, S., Sahay, K., Rizvanov, A. A., Lezhnyova, V., Хайбуллин, Т. И., Martynova, E. V., Khaiboullina, S. F., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.996469 · Cited by 170
Surgical excision of CNS‐draining lymph nodes reduces relapse severity in chronic‐relapsing experimental autoimmune encephalomyelitis
van Zwam, M., Huizinga, R., Heijmans, N., van Meurs, M., Wierenga‐Wolf, A. F., Melief, M., Hintzen, R. Q., Hart, B. A. ‘., Amor, S., Boven, L. A., et al. (2008) · The Journal of Pathology · doi:10.1002/path.2476 · Cited by 151
Microbial view of central nervous system autoimmunity
Berer, K., & Krishnamoorthy, G. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.007 · Cited by 153
Microglial autophagy–associated phagocytosis is essential for recovery from neuroinflammation
Berglund, R., Guerreiro-Cacais, A. O., Adzemovic, M. Z., Zeitelhofer, M., Lund, H., Ewing, E., Ruhrmann, S., Nutma, E., Parsa, R., Thessen-Hedreul, M., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abb5077 · Cited by 149
Disturbed regulatory T cell homeostasis in multiple sclerosis
Venken, K., Hellings, N., Liblau, R., & Stinissen, P. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.12.003 · Cited by 150
Clinical Stabilization and Effective B-Lymphocyte Depletion in the Cerebrospinal Fluid and Peripheral Blood of a Patient With Fulminant Relapsing-Remitting Multiple Sclerosis
Stüve, O., Cepok, S., Elias, B., Saleh, A., Hartung, H.-P., Hemmer, B., & Kieseier, B. C. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1620 · Cited by 149
A Population-based Ecologic Study of Inflammatory Bowel Disease: Searching for Etiologic Clues
Green, C. A., Elliott, L. J., Beaudoin, C. M., & Bernstein, C. N. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj260 · Cited by 148
Oral Administration of the Probiotic Strain Escherichia coli Nissle 1917 Reduces Susceptibility to Neuroinflammation and Repairs Experimental Autoimmune Encephalomyelitis-Induced Intestinal Barrier Dysfunction
Sécher, T., Kassem, S., Benamar, M., Bernard, I., Boury, M., Barreau, F., Oswald, É., & Saoudi, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01096 · Cited by 148
Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE
Van Kaer, L., Postoak, J. L., Wang, C., Yang, G., & Wu, L. (2019) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0221-5 · Cited by 148
HIV Infection of the Central Nervous System: Clinical Features and Neuropathogenesis
Lomax, L. B., Gill, M. J., & Power, C. (2008) · Neurologic Clinics · doi:10.1016/j.ncl.2008.04.002 · Cited by 147
Modulating the immune system through nanotechnology
Dacoba, T. G., Ana, O., Torres, D., Crecente‐Campo, J., & Alonso, M. J. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.09.007 · Cited by 150
CURCUMIN AND AUTOIMMUNE DISEASE
Bright, J. J. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-46401-5_19 · Cited by 147
A Tale of Two Citrullines—Structural and Functional Aspects of Myelin Basic Protein Deimination in Health and Disease
Harauz, G., & Musse, A. A. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9108-9 · Cited by 146
Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system
Larochelle, C., Cayrol, R., Kebir, H., Alvarez, J. I., Lécuyer, M.-A., Ifergan, I., Viel, É., Bourbonnière, L., Beauseigle, D., Terouz, S., et al. (2012) · Brain · doi:10.1093/brain/aws212 · Cited by 145
Regulation of the severity of neuroinflammation and demyelination by TLR‐ASK1‐p38 pathway
Guo, X., Harada, C., Namekata, K., Matsuzawa, A., Camps, M., Ji, H., Swinnen, D., Jorand‐Lebrun, C., Muzerelle, M., Vitte, P., et al. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000103 · Cited by 146
Signaling via the RIP2 Adaptor Protein in Central Nervous System-Infiltrating Dendritic Cells Promotes Inflammation and Autoimmunity
Shaw, P. J., Barr, M., Lukens, J. R., McGargill, M. A., Chi, H., Mak, T. W., & Kanneganti, T. (2011) · Immunity · doi:10.1016/j.immuni.2010.12.015 · Cited by 144
Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE
van Zwam, M., Huizinga, R., Melief, M., Wierenga‐Wolf, A. F., van Meurs, M., Voerman, J. S. A., Biber, K. P. H., Boddeke, H. W. G. M., Höpken, U. E., Meisel, C., et al. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0421-4 · Cited by 148
Lithium Prevents and Ameliorates Experimental Autoimmune Encephalomyelitis
Sarno, P. D., Axtell, R. C., Raman, C., Roth, K. A., Alessi, D. R., & Jope, R. S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.338 · Cited by 146
The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis
Mallucci, G., Peruzzotti‐Jametti, L., Bernstock, J. D., & Pluchino, S. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.02.003 · Cited by 153
Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells
Kivisäkk, P., Healy, B. C., Viglietta, V., Quintana, F. J., Hootstein, M. A., Weiner, H. L., & Khoury, S. J. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a8266f · Cited by 145
TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab
Oreja‐Guevara, C., Ramos‐Cejudo, J., Aroeira, L. S., Chamorro, B., & Díez‐Tejedor, E. (2012) · BMC Neurology · doi:10.1186/1471-2377-12-95 · Cited by 141
Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing‐remitting multiple sclerosis
Novakova, L., Axelsson, M., Khademi, M., Zetterberg, H., Blennow, K., Malmeström, C., Piehl, F., Olsson, T. P., & Lycke, J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13881 · Cited by 147
Molecular mechanisms of T‐cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy
Podojil, J. R., & Miller, S. D. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00773.x · Cited by 144
Critical regulation of CD4+ T cell survival and autoimmunity by β-arrestin 1
Shi, Y., Feng, Y., Kang, J., Liu, C., Li, Z., Li, D., Cao, W., Qiu, J., Guo, Z., Bi, E., et al. (2007) · Nature Immunology · doi:10.1038/ni1489 · Cited by 141
IL‐10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis
Martínez‐Forero, I., García‐Muñoz, R., Martinez‐Pasamar, S., Inogés, S., de Cerio, A. L.-D., Palacios, R., Sepulcre, J., Moreno, B., Gonzalez, Z., Fernández-Díez, B., et al. (2008) · European Journal of Immunology · doi:10.1002/eji.200737271 · Cited by 141

Authors: Sospedra, M., & Martin, R.
Affiliations: National Institutes of Health (US)
Cellular Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1400;
ORCID: Sospedra, Mireia
Venue: Annual Review of Immunology
Publisher: Annual Reviews
Published: 2005-04-01
Volume: 23
Issue: 1
Pages: 683-747
ISSN: 0732-0582 (ISSN-L)
1545-3278
DOI: 10.1146/annurev.immunol.23.021704.115707
OpenAlex: W2113291839
Cited by: 2,149
References: 362
Citations by year: 2026: 27 · 2025: 43 · 2024: 62 · 2023: 64 · 2022: 69 · 2021: 72 · 2020: 78 · 2019: 84 · 2018: 71 · 2017: 110 · 2016: 107 · 2015: 149 · 2014: 133 · 2013: 144 · 2012: 120
FWCI: 19.06
Type: journal article
Language: en
Open access: closed
Locations: Annual Review of Immunology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords: multiple sclerosis, autoimmunity, CD4+ T cells, Th1 cells, Th2 cells, regulatory T cells, natural killer cells, CD8+ T cells, complement system, autoantibodies, innate immunity, viral triggers, genetic susceptibility, relapsing-remitting disease, chronic progressive disease, central nervous system, neuroimmune interactions
MeSH terms: Autoantibodies, Autoantigens, Central Nervous System, HLA Antigens, Humans, Immunity, Innate, Immunogenetics, Infections, Multiple Sclerosis, Myelin Proteins, T-Lymphocyte Subsets, Cytokines, Models, Immunological, Molecular Mimicry, Chemokines, Genomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

IMMUNOLOGY OF MULTIPLE SCLEROSIS

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks